Osteoporosis Screening in Sherman, TX at DFWPMA

Looking for osteoporosis screening in Sherman? At DFW Physicians Medical Associates (DFWPMA), our endocrinology and primary care providers offer bone health evaluations, osteoporosis risk assessments, and preventive healthcare to help patients identify bone loss and reduce their likelihood of fractures.

Osteoporosis screening evaluates bone mineral density and fracture risk, often using a dual-energy X-ray absorptiometry (DXA) scan to measure bone strength. Screening can identify osteoporosis or low bone mass before a fracture occurs, allowing patients to receive appropriate medical evaluations and treatment recommendations when needed.

Whether you’re approaching menopause, concerned about age-related bone loss, or have medical conditions that increase osteoporosis risk, DFWPMA Sherman offers individualized evaluations to help determine whether bone density testing is appropriate based on your age, medical history, and fracture risk factors.

Book an appointment online or call (903) 957-0082 to contact our Sherman location.
Address: 📍
425 N Highland Ave., Suite 260, Sherman, TX 75092

Click here to get directions

We accept many major insurance plans. Not sure if your plan is accepted?

Call (903) 957-0082 and our team can help verify coverage.

Why Choose DFWPMA for Osteoporosis Screening in Sherman?

DFW Physicians Medical Associates provides osteoporosis screening evaluations in Sherman through endocrinology and primary care providers experienced in bone health, preventive screenings, hormonal disorders, chronic disease management, and individualized medical care.

Patients seeking osteoporosis screening at DFWPMA Sherman can benefit from:

  • Specialized Endocrinology Expertise: Access to Dr. Gitana Staskus, a board-certified endocrinologist with more than 20 years of experience treating osteoporosis, hormonal disorders, and metabolic conditions.
  • Experienced Primary Care Providers: Preventive healthcare evaluations from Aniwelyn Tan, DNP, and Dr. Ayodya Perera, whose backgrounds support chronic disease management, preventive screenings, and individualized medical care.
  • Individualized Osteoporosis Risk Assessment: Review of age, menopause status, fracture history, family history, medication use, and other factors that may contribute to reduced bone density.
  • Bone Density Testing Guidance: Evaluation of whether DXA scanning is appropriate and coordination of diagnostic testing when medically indicated.
  • Hormonal and Metabolic Evaluations: Assessment of thyroid disorders, hormonal abnormalities, and other medical conditions that may contribute to osteoporosis or increased fracture risk.
  • Fracture Prevention Education: Guidance regarding physical activity, calcium and vitamin D intake, fall prevention, and other measures that support healthy bones.
  • Coordinated Osteoporosis Care: Access to primary care evaluations, specialized endocrinology assessments, and appropriate follow-up after abnormal bone density findings.

Osteoporosis screening is most effective when healthcare providers evaluate individual fracture risk and recommend appropriate follow-up after abnormal results. Screening decisions should consider age, menopause status, underlying medical conditions, and other risk factors rather than applying the same testing approach to every patient.

Schedule an appointment with DFWPMA Sherman to discuss osteoporosis screening and your long-term bone health needs.

Meet Our Osteoporosis Screening Providers in Sherman

Dr. Gitana Staskus, MD — Board-Certified Endocrinologist

Dr. Gitana Staskus is a board-certified endocrinologist with more than 20 years of clinical experience diagnosing and treating endocrine and metabolic disorders in adults and older adults. Her areas of expertise explicitly include osteoporosis, bone health, thyroid disease, hormonal disorders, and other conditions affecting metabolism.

Her specialized background supports osteoporosis screening evaluations, assessment of hormonal and metabolic causes of bone loss, and individualized osteoporosis treatment planning. Dr. Staskus emphasizes patient education, evidence-based medical care, and collaborative decision-making to help patients understand their bone density results, fracture risk, and appropriate treatment options.

Aniwelyn Tan, DNP — Family Nurse Practitioner

Aniwelyn Tan is a family nurse practitioner and primary care provider with more than 20 years of clinical experience. Her background includes cardiovascular intensive care nursing at Baylor Scott & White Hospital in Plano, along with experience in internal medicine-related care and chronic disease management. She holds Family Nurse Practitioner certification and Cardiovascular Nurse Practitioner Board Certification.

Her primary care background supports preventive bone health evaluations, osteoporosis risk assessment, and recommendations for appropriate bone density screening. Tan provides individualized medical guidance for patients ages 15 and older, helping identify relevant medical risk factors and coordinate additional diagnostic testing or specialist care when necessary.

Dr. Ayodya Perera, MD — Family Medicine Physician

Dr. Ayodya Perera is a family medicine physician providing comprehensive primary care and preventive healthcare for adolescents and adults ages 15 and older. She earned her medical degree from Tbilisi State Medical University and completed her Family Medicine Residency through New York Medical College at Hoboken University Hospital. Her clinical interests include preventive screenings, chronic disease management, weight management, and women’s health.

Dr. Perera’s experience in preventive medicine and women’s healthcare supports osteoporosis risk evaluations, screening recommendations for postmenopausal patients, and discussions about maintaining bone health. She emphasizes patient education, shared decision-making, and individualized medical care to help patients understand fracture risk and appropriate preventive strategies.

Book an appointment online to inquire about osteoporosis screening, bone health assessments, and endocrinology care with our Sherman providers.

What Can Osteoporosis Screening in Sherman Help With?

Osteoporosis screening helps identify reduced bone mineral density and assess fracture risk in patients who may have weakened bones without experiencing noticeable symptoms. Bone density testing can detect osteoporosis or osteopenia, while clinical risk assessment helps determine whether additional evaluation or treatment may be necessary.

At DFWPMA Sherman, osteoporosis screening evaluations and related preventive healthcare may help with:

  • Osteoporosis Detection: Identifying low bone mineral density consistent with osteoporosis, a condition associated with an increased likelihood of fractures.
  • Osteopenia Identification: Detecting bone density below the normal range but not sufficiently reduced to meet the diagnostic threshold for osteoporosis.
  • Postmenopausal Bone Loss: Evaluating osteoporosis risk in postmenopausal women, especially those with additional factors associated with increased fracture susceptibility.
  • Age-Related Fracture Risk: Assessing bone health and fracture risk in older adults, particularly women ages 65 and older.
  • Secondary Causes of Bone Loss: Identifying hormonal disorders, metabolic conditions, or medications that may contribute to reduced bone density and require additional medical evaluation.
  • Individualized Prevention Planning: Determining whether bone density testing, additional diagnostic evaluation, fracture prevention counseling, or osteoporosis treatment is appropriate.

According to the U.S. Preventive Services Task Force (USPSTF), its 2025 recommendation supports osteoporosis screening for women ages 65 and older. Screening is also recommended for postmenopausal women younger than 65 who have one or more risk factors and are determined to have increased fracture risk through clinical assessment.

For men, the USPSTF concludes that current evidence is insufficient to determine the balance of benefits and harms of routine osteoporosis screening. Providers may use individualized clinical judgment when evaluating men with significant fracture risk factors.

These recommendations apply to adults without known osteoporosis, previous fragility fractures, or certain medical conditions and medications associated with secondary osteoporosis.

Osteoporosis screening is not equivalent to diagnosing the cause of a fracture or evaluating every type of bone disease. Patients with fractures following minimal trauma, established metabolic bone disorders, or prolonged medication exposure affecting bone strength may need diagnostic evaluation rather than routine preventive screening alone.

What Osteoporosis Screening Services Are Available in Sherman?

Osteoporosis screening services involve evaluating fracture risk factors, determining whether bone mineral density testing is appropriate, and reviewing available results to identify patients who may benefit from further assessment or treatment. DXA scanning is the standard imaging technique used to measure bone density, although test availability and scheduling arrangements should be confirmed.

At DFWPMA Sherman, preventive bone health evaluations and osteoporosis-related care may include:

  • Osteoporosis Risk Assessment: Reviewing age, menopause status, previous fractures, family history, body weight, smoking history, and other factors associated with increased fracture risk.
  • Bone Density Testing Evaluation: Determining whether a DXA scan is recommended and coordinating testing when medically indicated and available.
  • Fracture Risk Evaluation: Assessing clinical risk factors and potentially using validated fracture risk prediction tools to guide screening and management decisions.
  • Bone Density Results Review: Interpreting available DXA findings, including T-scores when applicable, to evaluate bone mineral density and determine appropriate follow-up.
  • Hormonal and Metabolic Assessment: Evaluating thyroid disorders, hormonal abnormalities, and other medical conditions that may contribute to bone loss when clinically appropriate.
  • Preventive Bone Health Counseling: Providing individualized recommendations regarding calcium and vitamin D intake, weight-bearing and resistance exercise, fall prevention, and modifiable fracture risk factors.
  • Osteoporosis Treatment and Follow-Up: Evaluating abnormal screening findings, discussing appropriate treatment options, and coordinating specialized endocrinology care when indicated.

During a DXA scan, low-dose X-ray imaging measures bone mineral density, commonly at the hip and lumbar spine. The procedure is generally painless and noninvasive. Results are interpreted alongside age, fracture history, medical conditions, and other factors influencing bone health.

A DXA T-score of -2.5 or lower at an accepted skeletal site generally meets the bone density criterion for osteoporosis in postmenopausal women and men ages 50 and older. Scores between -1.0 and -2.5 indicate low bone mass. Bone density results alone do not capture every factor contributing to fracture risk, and different interpretation criteria apply to younger individuals.

Osteoporosis screening should follow evidence-based recommendations and individualized fracture risk assessment. Patients diagnosed with osteoporosis may benefit from further evaluation, medication when appropriate, and preventive measures to reduce fracture risk. Repeat bone density testing intervals should depend on clinical findings, treatment decisions, and individual circumstances rather than automatically occurring every year.

Looking for osteoporosis screening in Sherman? Contact DFWPMA at (903) 957-0082 or book an appointment online to schedule a bone health evaluation, discuss DXA testing availability, and explore personalized osteoporosis care with our primary care and endocrinology providers.